Home>> About Jupiter >> Subsidaries >> Jupiter Bioscience AG
Jupiter Bioscience AG, Switzerland
Overview
The company’s manufacturing facilities are located at Laufengen, Switzerland. The company has acquired the manufacturing facilities from Merck Biosciences in Switzerland.
Rationale of the facility
The facility has been acquired to service the customers in the regulated markets especially Europe. Further, as the facility was designed for manufacturing peptide building blocks and peptide APIs and also complied with GMP requirements the facility will facilitate Jupiter Bioscience to enter the segment of generic peptide APIs and clinical peptide APIs much faster.
Advantages to the customer
In Europe there are many companies which are developing new drug candidates based on peptides. This facility will cater to these customers in supporting their requirement from custom synthesis of peptides to APIs for clinical trials from phase I to phase III.
Technology Focus
This subsidiary is dedicated for manufacturing peptides by the solution phase synthesis.
Business Segments
The business segments of this subsidiary are:
- Custom synthesis of peptides and peptidomimetics
- APIs for peptide in clinical trials by solid phase
- Generic peptide APIs by solution phase
Operations
The facility is currently managed by Mr. Rudolf Tanner who has got more than 30 years experience in solution phase peptide synthesis. He is assisted by well trained staff in operations.
Details of the facility
The manufacturing facility comprises an area of 40000 Square feet and has the following sections:
The manufacturing facility comprises following sections:
- Production and Purification
- Clean room area for sterile filling and lyophilization
- Raw material, WIP and finsihed material storage facility
- Quality Control & Quality Assurance set up